tizanidine
CHEBI:CHEBI_63629
Definition
2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
Chemical Information
- Molecular Formula
- C9H8ClN5S
- Molecular Mass
- 253.71100
- Charge
- 0
- SMILES
- Clc1ccc2nsnc2c1NC1=NCCN1
- InChI
- InChI=1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13)
- InChIKey
- XFYDIVBRZNQMJC-UHFFFAOYSA-N
Alternative Names
- 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole
- 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine
- tizanidina
- tizanidine
- Tizanidine
- tizanidinum
Drug Classification
-
imidazolesView Class →
CHEBI:24780
-
benzothiadiazoleView Class →
CHEBI:48864
-
t262537
-
t262648
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 57258
- oboInOwl#hasDbXref
- Wikipedia:Tizanidine
- core#notation
- CHEBI:63629
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 57258
- oboInOwl#hasDbXref
- Wikipedia:Tizanidine
- oboInOwl#id
- CHEBI:63629
- oboInOwl#hasAlternativeId
- CHEBI:9608
- generic_name
- Tizanidine HCL
- brand_name
- Tizanidine HCL
- brand_name_base
- Tizanidine HCL
- product_ndc
- 71610-114
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35569
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- CAPSULE, GELATIN COATED
- labeler_name
- ADVANCED RX PHARMACY OF TENNESSEE, LLC
- marketing_start_date
- 19961127
- application_number
- ANDA076280
- package_ndc
- 80425-0453-1
- package_description
- 120 TABLET in 1 BOTTLE (50090-0840-0)
- package_marketing_start_date
- 29-APR-14
- route
- ORAL
- spl_id
- d3850e2b-1b17-3f80-72ff-dac1541d9c08
- manufacturer_name
- ADVANCED RX PHARMACY OF TENNESSEE, LLC
- listing_expiration_date
- 20241231
- rxcui
- 485486
- unii
- 6AI06C00GW
- spl_set_id
- c46c7aa3-69db-82dc-e053-2995a90ac251
- has_treatment
- http://purl.obolibrary.org/obo/DOID_0111238
- core#notation
- CHEBI:63629
- active_ingredient_strength
- 1 kg/kg
- active_ingredient_name
- TIZANIDINE
- upc
- 0363187673307
- pharm_class_moa
- Adrenergic alpha2-Agonists [MoA]
- pharm_class
- Central alpha-2 Adrenergic Agonist [EPC]
- pharm_class_epc
- Central alpha-2 Adrenergic Agonist [EPC]
- nui
- N0000175554
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30705
- owl#annotatedSource
- t262800
- owl#someValuesFrom
- t952182